NCT03609970

Brief Summary

The optimal way to restore serum 25-hydroxyvitamin D sufficiency is currently debatable. UV irradiation through sunshine exposure promotes endogenous vitamin D synthesis, although this can also be associated with a risk of UVR-induced skin cancer. Dietary supplements represent an alternative, which are increasingly being used in clinical trials to correct deficiency. However, it is unclear whether sunshine exposure and vitamin D supplementation induce comparable changes in immune function, or whether additional UVR-induced molecules may be responsible for proposed health benefits. Several studies report an inverse correlation between exposure to UVR and immune-mediated diseases, further supporting the theory that UVR may also be protective through non vitamin-D mediated pathways. So far it has been difficult to distinguish between immune-regulation by vitamin D and other mediators induced by UVR as the downstream effects are similar. A direct comparison of the biological effects of vitamin D obtained by UVR versus supplementation has never been made. This study aims to elucidate the differences in vitamin D generated by UVR exposure versus supplementation by comparing immunological endpoints

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
36

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Nov 2015

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 19, 2015

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 14, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 14, 2017

Completed
1.2 years until next milestone

First Submitted

Initial submission to the registry

June 22, 2018

Completed
1 month until next milestone

First Posted

Study publicly available on registry

August 1, 2018

Completed
Last Updated

August 1, 2018

Status Verified

July 1, 2018

Enrollment Period

1.4 years

First QC Date

June 22, 2018

Last Update Submit

July 25, 2018

Conditions

Keywords

Vitamin DUVRImmune system

Outcome Measures

Primary Outcomes (1)

  • Vitamin D status of healthy participants treated with oral vitamin D (cholecalciferol) or UVR (SSR) exposures and control (untreated)

    Measure 25(OH)D3nmol/L via LC-MS/MS

    3 years

Secondary Outcomes (3)

  • Changes to peripheral blood cell frequency

    3 years

  • Impact upon the frequency and phenotype of peripheral blood dendritic cells

    3 years

  • Gene expression in peripheral blood myeloid and plasmacytoid dendritic cells

    3 years

Study Arms (3)

Control

NO INTERVENTION

No intervention

UVR (Solar simulated radiation)

EXPERIMENTAL

Twice weekly 1.25 SED (sub-erythemal) (4 weeks)

Radiation: UVR (Solar simulated radiation)

Vitamin D3 supplementation

EXPERIMENTAL

4X 1000IU cholecalciferol tablets daily (28 days)

Dietary Supplement: Vitamin D

Interventions

Vitamin DDIETARY_SUPPLEMENT

Daily 4X 1000IU cholecalciferol

Vitamin D3 supplementation

1.25 SED Solar simulated radiation twice weekly

UVR (Solar simulated radiation)

Eligibility Criteria

Age18 Years - 40 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Age: 18-40
  • Fitzpatrick skin type I/II
  • Healthy
  • Serum 25(OH)D3 \<50nmol/L

You may not qualify if:

  • Serum 25(OH)D3 \>50nmol/L
  • Pregnant or nursing women
  • Women of child bearing age not using adequate contraception
  • Are taking photosensitizing medication (i.e. causes you to be more sensitive to sunlight)
  • Have had a history of skin disorders, sensitive skin, sensitivity to sunlight or skin cancer
  • Have previously had an organ transplant
  • Have partaken in a clinical study within the last 14 days
  • Have had recent exposure to sunbeds (last 4 months) or holiday sun (including skiing)
  • Are currently or have taken vitamin D supplements in the last 4 months Are asthmatic or suffer from any allergies

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Vitamin D Deficiency

Interventions

Vitamin D

Condition Hierarchy (Ancestors)

AvitaminosisDeficiency DiseasesMalnutritionNutrition DisordersNutritional and Metabolic Diseases

Intervention Hierarchy (Ancestors)

SecosteroidsSteroidsFused-Ring CompoundsPolycyclic Compounds

Study Officials

  • Antony Young

    King's College London

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 22, 2018

First Posted

August 1, 2018

Study Start

November 19, 2015

Primary Completion

April 14, 2017

Study Completion

April 14, 2017

Last Updated

August 1, 2018

Record last verified: 2018-07

Data Sharing

IPD Sharing
Will not share